Synthesis, crystal structure, DFT studies and biological activity of (Z)-3-(3-bromophenyl)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxyprop-2-en-1-one
- PMID: 30474759
- PMCID: PMC6768133
- DOI: 10.1186/s13065-018-0492-4
Synthesis, crystal structure, DFT studies and biological activity of (Z)-3-(3-bromophenyl)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxyprop-2-en-1-one
Abstract
Background: Nowadays, is emerging a new generation of highly promising inhibitors bearing the β-ketoenol functionality. The present work relates to the first synthesis, the structure determination, the DFT studies and the use of a new biomolecule designed with a β-ketoenol group bounded to a pyrazolic moiety.
Result: A novel β-ketoenol-pyrazole has been synthesized, well characterized and its structure was confirmed by single crystal X-ray diffraction. The electron densities and the HOMO-LUMO gap have been calculated using the DFT method with BLYP, PW91, PWC functionals and 6-31G* basis set. An evaluation of the molecule stability is provided by a NBO analysis and the calculated Fukui and Parr functions have been used to locate the reactive electrophile and nucleophile centers in the molecule. The synthesized compound, screened for its in vitro antifungal behavior against the Fusarium oxysporum f.sp. albedinis FAO fungal strains, shows a moderate activity with an inhibition percentage of 46%. The product was also tested against three bacterial strains (Escherichia coli, Bacillus subtilis and Micrococcus luteus), but no significant effect was observed against these organisms.
Conclusions: Density functional calculations are used to evaluate the HOMO-LUMO energy gap, the molecular electrostatic potential and to provide a natural bond orbital analysis. The measured antimicrobial activities encourage us to continue searching for other structures, likely to be good antifungal candidates.
Keywords: Biological activity; Fukui and Parr functions; NBO analysis; Reactivity indices; Single-crystal structure; β-Keto-enol-pyrazole.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- Dowling C, Murphy VJ, Parkin G. Bis(pyrazolylethyl) ether ligation to zinc and cobalt: meridional vs facial coordination and the suitability of such ligands in providing a NNO donor set for modeling bioinorganic aspects of zinc chemistry. Inorg Chem. 1996;35:2415–2420. doi: 10.1021/ic9512744. - DOI - PubMed
-
- Haanstra WJ, Driessen WL, Van Roon M, Stoffels ALE, Reedijk J. Co-ordination compounds with the N 2 S-donor ligand 1, 5-bis (3, 5-dimethylpyrazol-1-yl)-3-thiapentane. J Chem Soc Dalton Trans. 1992;3:481–486. doi: 10.1039/dt9920000481. - DOI
-
- Driessen WL, Wiesmeijer WGR, Schipper-Zablotskaja M, De Graaff RAG, Reedijk J. Transition metal coordination compounds of two pyrazole-substituted ammonia ligands. X-ray structure of [Biss(1-pyrazolylmethyl)aminecobalt(II)] bis(nitrate) Inorg Chim Acta. 1989;162:233–238. doi: 10.1016/S0020-1693(00)83153-9. - DOI
-
- Pennings YCM, Driessen WL, Reedijk J. Copper(I) coordination compounds with two bidentate chelating pyrazole ligands. X-ray crystal structures of DI-μ-chloro-bis[[N, N-bis(1- pyrazolylmethyl)aminoethane]copper(I)] and [bis(N, N-bis(1-pyrazolylmethyl)aminoethane]copper(I) triflate. Polyhedron. 1988;7:2583–2589. doi: 10.1016/S0277-5387(00)83877-2. - DOI
-
- Veldhuis JB, Driessen WL, Reedijk JA. A pyrazole derivative of aminoethane as a tridentate chelating ligand towards transition metals. The X-ray structure of [N, N-bis(pyrazol-1-ylmethyl)aminoethane]dibromocopper(II. Chem Soc Dalton Trans. 1986;3:537–541. doi: 10.1039/dt9860000537. - DOI
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
